U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864403) titled 'Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch' on March 03.
Brief Summary: The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer are:
Does mirikizumab reduce symptoms of pouch disorders
Participants will:
Take mirikizumab every 4 weeks for one year Visit the clinic once every month for two months and at the end of the study Keep a diary of their symptoms
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Pouchitis
Pouches, Ileoanal
Pouch, Ileal
Intervention:
DRUG: Mirikizumab - Intravenous (IV)...